Cryosite Limited (ASX: CTE)
Health Care · Life Sciences Tools & Services · AU
AU$1.25
— today · +56.3% 1Y
Cryosite Limited (ASX: CTE) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $43.17M and employs 27 people.
Over the last twelve months the share price has gained 56.3%, trading between 0.72 and 1.31.
Tweenvest scores Cryosite Limited across four factors: quality 78/100, value 39/100, growth 35/100. Its strongest factor is quality.
CTE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.17M
- Revenue (TTM)
- $11.55M
- P/E
- 28.80
- EPS
- 0.04
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- AU$1.31
- 52-week low
- AU$0.72
- Avg volume (3M)
- —
- Shares outstanding
- 48.81M
- Employees
- 27
- Next earnings
- —
About Cryosite Limited
Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions. Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation. The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.
- ISIN
- AU000000CTE1
- Founded
- 1999
- Listed since
- May 9, 2002
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $628.74 | -0.08% |
| Danaher CorporationNYSE: DHR | $153.85B | $215.11 | -1.71% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF587.80 | -0.74% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $153.43 | -3.50% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $260.24 | +0.16% |
| Waters CorporationNYSE: WAT | $40.35B | $410.75 | +0.01% |
Figures last refreshed Aug 18, 2026.